Author:
Small Eric J.,Carducci Michael A.,Burke James M.,Rodriguez Ron,Fong Lawrence,van Ummersen Lynn,Yu D.C.,Aimi Junko,Ando Dale,Working Peter,Kirn David,Wilding George
Subject
Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine
Reference41 articles.
1. Replication-selective virotherapy for cancer: biological principles, risk management and future directions;Kirn;Nat Med.,2001
2. Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer;Kirn;Oncogene,2000
3. An adenovirus E1A mutant that demonstrates potent and selective antitumoral efficacy;Heise;Nat. Med.,2000
4. ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents;Heise;Nat. Med.,1997
5. A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy;DeWeese;Cancer Res.,2001
Cited by
197 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献